SET Announcements | Interpharma Group (IP)

Schedule for the Extraordinary General Meeting of Shareholders No. 1/2022, the capital reduction and increase of registered capital, the offering of new shares to PP and Increasing Capital under General Mandate

Management Discussion and Analysis Quarter 1 Ending 31 Mar 2022

Financial Performance Quarter 1 (F45) (Reviewed)

Financial Statement Quarter 1/2022 (Reviewed)

Publication of the Minute of the 2022 Annual General Meeting of Shareholders on the Company's Website

Shareholders meeting's resolution

Report on the results of the Exercise of IP-W1 (F53-5)

Publication of the Invitation to the 2022 Annual General Meeting of Shareholders on the Company's Website

Board Resolution of Omitted Dividend Payment, Extension of Increasing Capital under General Mandate, Changing the Objectives of Using the IPOs Proceed and Scheduling of 2022 Annual General Meeting of Shareholders (Revised)

Notification the exercise of IP-W1

Form to Report on Names of Members and Scope of Work of the Audit Committee (F24-1)

25 February 2022

Board Resolution of Omitted Dividend Payment, Extension of Increasing Capital under General Mandate, Changing the Objectives of Using the IPOs Proceed and Scheduling of 2022 Annual General Meeting of Shareholders

25 February 2022